Health
UK is getting Pfizer’s COVID-19 vaccine next week, but India will have to wait till April for Covishield – Moneycontrol
Serum Institute’s COVID-19 vaccine supply to private companies and in the open market will start only after orders from the government are met.
COVID-19 vaccine (representative image)
Serum Institute of India (SII) is likely to start selling its COVID-19 vaccine in the open market after March-April 2021 as there is a substantial demand from companies which want to buy doses in bulk for their employees, The Economic Times reported.
In an email response to the newspaper, SII CEO Adar Poonawalla confirmed that private market availability will probably be post March-April 2021, if the vaccine is found to be immunogenic and safe.
While initial…
Continue Reading
